Office of Primary Care and Area Health Education Centers (AHEC) Program

On Thursday, August 16, the National Institute of Allergy and Infectious Diseases (NIAID) announced that vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine.

A study co-authored by Donald Leopold, M.D., UVM clinical professor of surgery, is co-focuses on phantom odors in aging Americans. According to the study, 1 in 15 Americans over the age of 40 experience smelling unpleasant scents with no apparent source.

On July 22, 2018, a "Letter to the Community" submitted by the clinical chairs of the UVM Larner College of Medicine was published as a Commentary in VTDigger.

Margaret Tandoh, M.D., UVM Assistant Professor of Surgery, spoke with WCAX about ways parents can protect their kids against burns during the hot summer months.

An article, titled "Academics pitching practical research" and highlighting UVM's SPARK-VT program, was posted today on InsideHigherEd.com .

In an interview with WCAX, Frances Carr, M.D., UVM professor of pharmacology, spoke about the new federal PFOA health standard.

University of Vermont President Tom Sullivan today announced the appointment of Richard L. Page, M.D., as the 18th dean of the Larner College of Medicine at UVM, effective October 1, 2018.

A blog post by medical student Sunit Misra '19 was featured in the Association of American Medical College's Aspiring Docs Diaries.

In May, CNN published an article about the removal of a 132-pound ovarian tumor from a woman at Danbury Hospital in Connecticut, a branch clinical campus of UVM Larner College of Medicine.

An April 2018 CNN article highlights UVM’s medical cannabis courses and includes comments by Kalev Freeman, M.D., UVM assistant professor of surgery, and Monique McHenry, Ph.D., assistant professor of pharmacology, regarding the importance of informing medical professionals about the potential uses of medicinal marijuana.

In a recent interview on WCAX Health Watch Guillermo Linares, M.D., UVM assistant professor of neurological sciences, discussed the importance of treating all Vermont stroke patients in the same way.

In an article posted on WCAX on March 21, 2018, Roger Knakal, M.D., assistant professor of orthopaedics and rehabilitation, discusses why stroke patients are often also treated for depression.

At a Vermont Statehouse hearing on February 8th, 2018, UVM Assistant Professor of Emergency Medicine Mariah McNamara, M.D., testified in favor of new gun control legislation that would require universal background checks on all gun sales in the state of Vermont.

On February 7, 2018, The Burlington Free interviewed Emily Tarleton, Ph.D., bionutrition research manager at the UVM Clinical Research Center, about a recent clinical trial conducted at the College relating to use of magnesium for treatment of mild to moderate depression.

In a February 6 Tech Transfer Central article, Vice President for Research at the University of Vermont (UVM), Richard Galbraith, M.D., Ph.D., spoke about UVM's recent joining of the Advanced Regenerative Manufacturing Institute (ARMI).

The Centers for Disease Control (CDC) has recently raised concerns about the effects of prescribed attention deficit hyperactivity disorder (ADHD) medication on unborn children. David Jones, M.D., director of the University of Vermont Medical Center Fetal Diagnostic Center, explains that while there is not much research on this topic, the risk of taking ADHD medication for women considering pregnancy is low.

On October 26, 2017, UVM Larner College of Medicine Senior Associate Dean for Medical Education William Jeffries, Ph.D., was interviewed by Eric Clemons for a Comcast Newsmakers segment on the College of Medicine’s active learning efforts.

On October 16, 2017, UVM Associate Professor of Psychiatry and Pediatrics David Rettew, M.D. was highlighted in the VT Digger article, "Vermont physicians propose go-slow approach on pot legalization," regarding two proposed resolutions to Vermont's medical marijuana program

On October 12, 2017, VPR’s Vermont Edition hosted Carlos Pino, M.D., UVM professor of anesthesiology, to discuss how physicians are managing pain in patients during the opioid crisis.

On September 26, 2017 Vermont Business Magazine highlighted the appointment of Adam Atherly, Ph.D., as the first Director of Health Services Research at the University of Vermont Larner College of Medicine.